Jubilant Pharmova Limited has informed the Exchange regarding Change in Director(s) of the company.

CFO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹1180.20

prior close

₹1146.90

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%-3.2% vs market

Pharmaceuticals peers, median of 149sector+0.8%-3.1% vs sector

On the reaction day the stock moved 3.2 pts less than Nifty Smallcap 250 and 3.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.3

15m

+0.4

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+0.9-3.2+0.8-3.1

Next day

+4.5+0.8+3.7+0.9+3.6

+1.2-0.1+1.3-0.1+1.3

-2.5-1.7-0.8-2.1-0.5

-2.8-0.8-2.0-1.4-1.4

-5.1-1.1-4.0-2.0-3.1

-6.6-2.4-4.2-3.3-3.3

15d

-8.2-0.6-7.6-3.1-5.1

-14.0-3.8-10.2-5.2-8.8

-9.7-2.9-6.8-5.7-4.0

-3.5+1.5-5.0-5.2+1.7

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Arvind Chokhany, the Group Chief Financial Officer and Whole-time Director of Jubilant Pharmova Limited, has resigned from the company to take up an external opportunity. He submitted his resignation letter on July 29, 2025, and will formally step down from his roles at the close of business on September 30, 2025. This gives the company about two months to arrange a transition and find a replacement for the CFO position. The announcement is a standard disclosure under SEBI's Listing Regulations.

Likely market impact

The departure of the CFO is a key management change that could create short-term uncertainty around financial leadership and continuity. Investors will watch closely for news of a successor, as a smooth transition is important to maintain investor confidence.